Lipophilicity of kinetically labile metal complexes through the example of antidiabetic Zn(II) and VO(IV) compounds

Journal of Pharmaceutical and Biomedical Analysis

Volumn 54, Issue 5, 2011, Pages 1073-1081

  Enyedy, Éva A ^a   Hollender, Dominik ^a   Kiss, Tamás ^a  

^a UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Deferiprone; Maltol; Octanol water distribution; Solution equilibrium; Speciation

Indexed keywords

2 HYDROXYPYRIDINE 1 OXIDE; 2,6 PYRIDINE DICARBOXYLIC ACID; 3 HYDROXY 1,2 DIMETHYL PYRIDINONE; 6 METHYLPICOLINIC ACID; ANTIDIABETIC AGENT; ANTIDIABETIC ZINC; DEFERIPRONE; LIGAND; MALTOL; METAL COMPLEX; METAL DERIVATIVE; METAL ION; PICOLINIC ACID; UNCLASSIFIED DRUG; ZINC DERIVATIVE;

ARTICLE; DISSOCIATION CONSTANT; HYDROPHILICITY; LIPOPHILICITY; PH; PHASE PARTITIONING; PHASE SEPARATION; PRIORITY JOURNAL; QUANTITATIVE STRUCTURE ACTIVITY RELATION; STOICHIOMETRY; ULTRAVIOLET SPECTROPHOTOMETRY; ZINC FINGER MOTIF;

CHLORIDES; HYPOGLYCEMIC AGENTS; KINETICS; LIGANDS; LIPIDS; MODELS, CHEMICAL; MOLECULAR STRUCTURE; ORGANOMETALLIC COMPOUNDS; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP; SOLUBILITY; SOLUTIONS; SPECTROPHOTOMETRY, ATOMIC; VANADATES; VANADIUM COMPOUNDS; WATER; ZINC; ZINC COMPOUNDS;

EID: 78751701410     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2010.12.025     Document Type: Article

References (45)

1. Avdeef A., Testa B. Physicochemical profiling in drug research: a brief survey of the state-of-the-art of experimental techniques. Cell. Mol. Life Sci. 2002, 59:1681-1689.
2. Poole S.K., Poole C.F. Separation methods for estimating octanol-water partition coefficients. J. Chromatogr. B 2003, 797:3-19.
3. Leo A., Hansch C., Elkins D. Partition coefficients and their uses. Chem. Rev. 1971, 71:525-616.
4. Valko K., Nunhuck S., Bevan C., Abraham M.H., Reynolds D.P. Fast Gradient HPLC method to determine compounds binding to human serum albumin. Relationships with octanol/water and immobilized artificial membrane lipophilicity. J. Pharm. Sci. 2003, 92:2236-2248.
5. VCCLAB, Virtual Computational Chemistry Laboratory, 2005. http://www.vcclab.org/.
6. Tetko I.V., Gasteiger J., Todeschini R., Mauri A., Livingstone D., Ertl P., Palyulin V.A., Radchenko E.V., Zefirov N.S., Makarenko A.S., Tanchuk V.Y., Prokopenko V.V. Virtual computational chemistry laboratory-design and description. J. Comput. Aid. Mol. Des. 2005, 19:453-463.
7. Sakurai H., Kojima Y., Yoshikawa Y., Kawabe K., Yasui H. Antidiabetic vanadium(IV) and zinc(II) complexes. Coord. Chem. Rev. 2002, 226:187-198.
8. Rehder D., Costa Pessoa J., Geraldes C.F.G.C., Castro M.M.C.A., Kabanos T., Kiss T., Meier B., Micera G., Pettersson L., Rangel M., Salifoglou A., Turel I., Wang D. In vitro study of the insulin-mimetic behaviour of vanadium(IV, V) coordination compounds. J. Biol. Inorg. Chem. 2002, 7:384-396.
9. Kiss T., Jakusch T., Hollender D., Dörnyei A., Enyedy E.A., Pessoa J.C., Sakurai H., Sanz-Medel A. Biospeciation of antidiabetic VO(IV) complexes. Coord. Chem. Rev. 2008, 252:1153-1162.
10. K.H. Thompson, VO(IV) complexes of maltol and ethylmaltol for oral treatment of type 2 diabetes mellitus: lessons from speciation studies and phase I and II clinical trials, Book of Abstracts, Sixth International Vanadium Symposium, Lisbon, 2008.
11. Sakurai H., Adachi Y. The pharmacology of the insulinomimetic effect of zinc complexes. Biometals 2005, 18:319-323.
12. Adachi Y., Yoshida J., Kodera Y., Kato A., Yoshikawa Y., Kojima Y., Sakurai H. A new insulin-mimetic bis(allixinato)zinc(II) complex: structure-activity relationship of zinc(II) complexes. J. Biol. Inorg. Chem. 2004, 9:885-893.
13. Thompson K.H., Barta C.A., Orvig C. Metal complexes of maltol and close analogues in medicinal inorganic chemistry. Chem. Soc. Rev. 2006, 35:545-556.
14. Slieman T.A., Nicholson W.L. Role of dipicolinic acid in survival of bacillus subtilis spores exposed to artificial and solar UV radiation. Appl. Environ. Microbiol. 2001, 67:1274-1279.
15. Peyroux E., Ghattas W., Hardre R., Giorgi M., Faure B., Simaan A.J., Belle C., Reglier M. Binding of 2-hydroxypyridine-N-oxide on dicopper(II) centers: insights into tyrosinase inhibition mechanism by transition-state analogs. Inorg. Chem. 2009, 48:10874-10876.
16. McGrath J., Murphy G.M. The control of Seborrheic dermatitis and dandruff by antipityrosporal drugs. Drugs 1991, 41:178-184.
17. Jakusch T., Gajda-Schrantz K., Adachi Y., Sakurai H., Kiss T., Horváth L. Solution equilibrium characterization of insulin-mimetic Zn(II) complexes. J. Inorg. Biochem. 2006, 100:1521-1526.
18. Sakurai H., Katoh A., Yoshikawa Y. Chemistry and biochemistry of insulin-mimetic vanadium and zinc complexes. Trial for treatment of diabetes mellitus. Bull. Chem. Soc. Japan 2006, 79:1645-1664.
19. Chaves S., Jelic R., Mendonca C., Carrasco M., Yoshikawa Y., Sakurai H., Santos M.A. Complexes of hydroxy(thio)pyrone and hydroxy(thio)pyridinone with Zn(II) and Mo(VI). Thermodynamic stability and insulin-mimetic activity. Metallomics 2010, 2:220-227.
20. Adachi Y., Yoshida J., Kodera Y., Katoh A., Takada J., Sakurai H. Bis(allixinato)oxovanadium(IV) complex is a potent antidiabetic agent: studies on structure-activity relationship for a series of hydroxypyrone-vanadium complexes. J. Med. Chem. 2006, 49:3251-3256.
21. Gans P., Sabatini A., Vacca A. Superquad-a new computer program for determination of stability constants of complexes by potentiometric titration. Inorg. Chim. Acta 1983, 79:219-220.
22. Nagypal I., Fabian I. NMR relaxation studies in solution of transition metal complexes. V. Proton exchange reactions in aqueous solutions of VO2+-oxalic acid, -malonic acid systems. Inorg. Chim. Acta 1982, 61:109-113.
23. Zékány L., Nagypál I. 8. PSEQUAD: A comprehensive program for the evaluation of potentiometric and/or spectrophotometric equilibrium data using analytical derivatives. Computational Methods for the Determination of Stability Constants 1985, 291-353. Plenum Press, New York. D.L. Leggett (Ed.).
24. Enyedy É.A., Lakatos A., Horváth L., Kiss T. Interactions of insulin-mimetic zinc(II) complexes with cell constituents: glutathione and ATP. J. Inorg. Biochem. 2008, 102:1473-1485.
25. Ferguson W.J., Braunschweiger K.I., Braunschweiger W.R., Smith J.R., McCormick J.J., Wasmann C.C., Jarvis N.P., Bell D.H., Good N.E. Hydrogen-ion buffers for biological research. Anal. Biochem. 1980, 104:300-310.
26. Hanlon D.P., Watt D.S., Westhead E.W. The interaction of divalent metal ions with tris buffer in dilute solution. Anal. Biochem. 1966, 16:225-233.
27. Sigel H., Scheller K.H., Prijs B. Metal ion/buffer interactions. Stability of alkali and alkaline earth ion complexes with triethanolamine (tea), 2-amino-2(hydroxymethyl)-1,3-propanediol (tris) and 2-[bis(2-hydroxyethyl)-amino] 2(hydroxymethyl)-1,3-propanediol (Bistris) in aqueous and mixed solvents. Inorg. Chim. Acta 1982, 66:147-155.
28. Fischer B.E., Haring U.K., Tribolet R., Sigel H. Metal ion/buffer interactions. Stability of binary and ternary complexes containing 2-amino-2(hydroxymethyl)-1,3-propanediol (Tris) and adenosine 5(-triphosphate (ATP). Eur. J. Biochem. 1979, 94:523-530.
29. Mash H.E., Chin Y.-P., Sigg L., Hari R., Xue H. Complexation of copper by zwitterionic aminosulfonic (Good) buffers. Anal. Chem. 2003, 75:671-677.
30. Taha M., Khalil M.M., Mohamed S.A. Metal ion buffer interactions. Complex formation of N,N-bis(2-Hydroxyethyl)glycine (bicine) with various biologically relevant ligands. J. Chem. Eng. Data 2005, 50:882-887.
31. Peral F., Gallego E. Self-association of pyridine-2,6-dicarboxylic acid in aqueous solution as determined from ultraviolet hypochromic and hyperchromic effects. Spectrochim. Acta Part A 2000, 56:2149-2155.
32. Ellis B.L., Duhme A.K., Hider R.C., Hossain M.B., Rizvi S., van der Helm D. Synthesis, physicochemical properties, and biological evaluation of hydroxypyranones and hydroxypyridinones: novel bidentate ligands for cell-labeling. J. Med. Chem. 1996, 39:3659-3670.
33. Kiss T., Jakusch M. Insulin-mimetic vanadium-containing compounds. Metallopharmaceutic Drugs and Metal-Based Diagnostic Agents 2005, 143-148. Wiley, Chichester. M. Gielen, E.R.T. Tieking (Eds.).
34. Kiss T., Jakusch T., Hollender D., Enyedy E.A., Horváth L. Comparative studies on the biospeciation of antidiabetic VO(IV) and Zn(II) complexes. J. Inorg. Biochem. 2009, 103:527-535.
35. Enyedy É.A., Horváth L., Gajda-Schrantz K., Galbács G., Kiss T. An in vitro study of interactions between insulin-mimetic zinc(II) complexes and selected plasma components. J. Inorg. Biochem. 2006, 100:1936-1945.
36. Guerra W., Silva I.R., Azevedo E.A., de A.R., Monteiro S., Bucciarelli-Rodriguez M., Chartone-Souza E., Silveira J.N., Fontes A.P.S., Pereira-Maia E.C. Three new complexes of platinum(II) with doxycycline, oxytetracycline and chlortetracycline and their antimicrobial activity. J. Braz. Chem. Soc. 2006, 17:1627-1633.
37. Rappel C., Galanski M., Yasemi A., Habala L., Keppler B.K. Analysis of anticancer platinum(II)-complexes by microemulsion electrokinetic chromatography: separation of diastereomers and estimation of octanol-water partition coefficients. Electrophoresis 2005, 26:878-884.
38. Rudnev A.V., Foteeva L.S., Kowol C., Berger R., Jakupec M.A., Arion V.B., Timerbaev A.R., Keppler B.K. Preclinical characterization of anticancer gallium(III) complexes: solubility, stability, lipophilicity and binding to serum proteins. J. Inorg. Biochem. 2006, 100:1819-1826.
39. Zhang Z., Rettig S.J., Orvig C. Lipophilic coordination compounds: aluminum, gallium, and indium complexes of 1-aryl-3-hydroxy-2-methyl-4-pyridinones. Inorg. Chem. 1991, 30:509-515.
40. John E.K., Green M.A. Structure-activity relationships for metal-labeled blood flow tracers: comparison of keto aldehyde bis(thiosemicarbazonato)copper(II) derivatives. J. Med. Chem. 1990, 33:1764-1770.
41. Danielsson L.G., Zhang Y.H., Sparen A. Mechanized method for measuring metal partition in n-octanol-aqueous systems. Partition of aluminium complexes. Analyst 1995, 120:2513-2519.
42. Jackson G.E., Mkhonta-Gama L., Voye A., Kelly M. Design of copper-based anti-inflammatory drugs. J. Inorg. Biochem. 2000, 79:147-152.
43. Kaiser S.M., Escher B.I. The evaluation of liposome-water partitioning of 8-hydroxyquinolines and their copper complexes. Environ. Sci. Technol. 2006, 40:1784-1791.
44. Buglyó P., Kiss E., Fabian I., Kiss T., Sanna D., Garribba E., Micera G. Speciation and NMR relaxation studies of VO(IV) complexes with several O-donor containing ligands: oxalate, malonate, maltolate and kojate. Inorg. Chim. Acta 2000, 306:174-183.
45. Rangel M., Tamura A., Fukushima C., Sakurai H. In vitro study of the insulin-like action of vanadyl-pyrone and -pyridinone complexes with a VO(O-4) coordination mode. J. Biol. Inorg. Chem. 2001, 6:128-132.